ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Wolfspeed and BCRX Flash Divergent Signals

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Options markets are sending sharp signals into the week's close — and the most interesting action sits away from mega-cap names.

WOLF stands out with extreme short positioning. Short interest hit 130% of free float. Borrow costs run at 8.7% APR. Available shares to borrow: zero. That zero-availability reading is a live squeeze trigger. The July expiry chain is active, with options running through July 17.

BCRX shows a striking split. Short sellers rebuilt positions this week. Yet options traders turned bullish simultaneously. That divergence — bears adding, calls buying — is a classic catalyst setup. BCRX carries 19.4% SI % FF with a cost to borrow near 1%. July 17 is the key expiry.

MU attracted analyst upgrades this week. Micron carries a $1.3 trillion market cap with just 3.7% SI % FF. It has near-daily expiries through September. Analysts lifting targets here often sparks call volume spikes.

NKE heads into its earnings window. Short interest sits at 5.1% of free float. Options run weekly from July 2 through September. Earnings volatility plays are likely building.

NVDA maintains the densest expiry schedule of any name — daily expirations through early July. At $4.7 trillion market cap and only 1.3% SI % FF, the action is purely directional. The June 29 and June 30 expiries are live now, making gamma exposure an active market factor into Sunday.

This is not financial advice.

Stocks in this article

How this article was generated

Generated
28 Jun 2026, 20:46
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.